Indi Molecular has an impressive pedigree, having been founded in 2013 by Leroy Hood of the Institute of Systems Biology, James Heath of Caltech and diagnostics entrepreneur Albert Luderer. It's a spinout from parent company Integrated Diagnostics that was first seeded with $1.8 million from Interwest Partners, Asset Management Ventures and angel investors.

The U.S. Food and Drug Administration has approved the Oncomine Dx Target Test from Thermo Fisher Scientific Inc. It is the first test of its kind to screen tumor samples for biomarkers associated with multiple cancer therapies, in this case for non-small-cell lung cancer (NSCLC). It is expected to enable more rapid evaluation of treatment options for these patients, in days rather than over several weeks. The test was developed in collaboration with Novartis AG and Pfizer Inc.; some of the first labs to offer it will include Laboratory Corporation of America's Diagnostics and Covance...

The U.S. Food and Drug Administration has approved the Oncomine Dx Target Test from Thermo Fisher Scientific Inc. It is the first test of its kind to screen tumor samples for biomarkers associated with multiple cancer therapies, in this case for non-small-cell lung cancer (NSCLC). It is expected to enable more rapid evaluation of treatment options for these patients, in days rather than over several weeks.

The FDA has approved the Oncomine Dx Target Test from Thermo Fisher Scientific Inc., the first test of its kind to screen tumor samples for biomarkers associated with multiple cancer therapies, in this case for non-small-cell lung cancer (NSCLC).

Royal Philips is slated to purchase Eugene, Ore.-based start up Electrical Geodesics Inc. to add its noninvasive brain activity monitoring and interpretation technology. The deal is expected to complement Philips existing imaging technology and neurological informatics portfolio to better address disorders such as stroke, epilepsy, traumatic brain injury and Parkinson's disease. Philips plans to use the start up's technology to enhance its neurological imaging, mapping and therapy guidance portfolio. EGI offers noninvasive neurodiagnostic and neuromodulation products to monitor, interpret and modulate brain activity using its dense array electroencephalography (dEEG) platform technology. Chasing neuro The newly...

Royal Philips is slated to purchase Eugene, Ore.-based start up Electrical Geodesics Inc. to add its noninvasive brain activity monitoring and interpretation technology. The deal is expected to complement Philips existing imaging technology and neurological informatics portfolio to better address disorders such as stroke, epilepsy, traumatic brain injury and Parkinson's disease.

Watson Health is working hard to demonstrate the seriousness of its ongoing efforts in oncology, highlighting its research and customers at the recent American Society of Clinical Oncology (ASCO) conference. The Boston-based IBM business had six presentations at ASCO based on its data and touted that its oncology product is being used at more than 55 cancer centers globally. But experts in the field of machine learning suggest that the real innovation and value-add for machine learning in oncology is in the analysis of radiology images, which are not addressed by the medical record and...